Amanote Research
Register
Sign In
Palivizumab and RSV Prevention
Archives of Disease in Childhood
- United Kingdom
doi 10.1136/adc.83.1.87a
Full Text
Open PDF
Abstract
Available in
full text
Categories
Child Health
Pediatrics
Perinatology
Date
July 1, 2000
Authors
W. LENNEY;
Publisher
BMJ
Related search
Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Infants With CHD &Premature Infants.
International Journal of Advanced Research
The Impact of the Recent AAP Changes in Palivizumab Authorization on RSV-induced Bronchiolitis Severity and Incidence
Italian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Retrospective Evaluation of Palivizumab Efficacy and Safety for RSV Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant Patients: A Single Center Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
P542 RSV Prophylaxis for Prevention of Recurrent Childhood Wheeze: A Systematic Review
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
PharmacoEconomics - Open
Health Policy
Pharmacology
Palivizumab and Prevention of Childhood Respiratory Syncytial Viral Infection: Protocol for a Systematic Review and Meta-Analysis of Breakthrough Infections
BMJ Open
Medicine
Sequence Variability of the Respiratory Syncytial Virus (RSV) Fusion Gene Among Contemporary and Historical Genotypes of RSV/A and RSV/B
PLoS ONE
Multidisciplinary
RSV Infection Among HIV-exposed Infants: Is RSV-IGIV Indicated?† 807
Pediatric Research
Child Health
Pediatrics
Perinatology
